Prestwick Pharmaceuticals
Washington, District of Columbia, United States
About Prestwick Pharmaceuticals
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $132.0M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2007)
- Website: prestwickpharma.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/prestwick-pharmaceuticals-2485188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.